8-K//Current report
Oruka Therapeutics, Inc. 8-K
Accession 0001213900-25-060352
$ORKACIK 0000907654operating
Filed
Jun 30, 8:00 PM ET
Accepted
Jul 1, 4:01 PM ET
Size
315.4 KB
Accession
0001213900-25-060352
Documents
- 8-Kea0247670-8k_oruka.htmPrimary
CURRENT REPORT
- EX-10.1ea024767001ex10-1_oruka.htm
OFFER LETTER, DATED JULY 1, 2025, BETWEEN ORUKA THERAPEUTICS, INC. AND LAURA SANDLER.
- GRAPHICex10-1_001.jpg
GRAPHIC
- EX-101.SCHorka-20250701.xsd
XBRL SCHEMA FILE
- EX-101.LABorka-20250701_lab.xml
XBRL LABEL FILE
- EX-101.PREorka-20250701_pre.xml
XBRL PRESENTATION FILE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001213900-25-060352-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLea0247670-8k_oruka_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Oruka Therapeutics, Inc.
CIK 0000907654
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000907654
Filing Metadata
- Form type
- 8-K
- Filed
- Jun 30, 8:00 PM ET
- Accepted
- Jul 1, 4:01 PM ET
- Size
- 315.4 KB